The most non-invasive FFR cardiovascular disease AI diagnostic platform in the world's leading product line

•Hangzhou ArteryFlow Technology Co., Ltd., founded in 2017, is a high-tech enterprise that combines biomedical engineering, three-dimensional medical image reconstruction, big data and artificial intelligence technology for precision medicine. 

•The company has developed a new non-invasive coronary artery detection technology, ECG artificial intelligence diagnosis technology, cerebral aneurysm risk assessment technology, etc., which is leading in China and synchronized internationally, and can significantly reduce treatment and diagnosis costs, improve diagnostic accuracy, reduce surgical risks, improve patient diagnostic comfort, etc. 

•It is jointly sponsored by more than 20 world-famous technical experts, doctors and famous doctors from Massachusetts Institute of Technology, the State University of New York, Imperial College of Technology and other interdisciplinary backgrounds. 

•It has carried out in-depth scientific research service cooperation with experts at the director level or the national organizing committee level in many domestic top three hospitals, and many research achievements have been published in international top journals.